Socioeconomic Status Does Not Replace Technical and Clinical Capability

Federal socioeconomic contracting policy derives from the Small Business Act (15 U.S.C. § 631 et seq.), including the government-wide goals in 15 U.S.C. § 644(g). The statutory goals are at least 23 percent of prime-contract value for small businesses overall; 5 percent of prime- and subcontract value for service-disabled veteran-owned small businesses (SDVOSBs); 5 percent for small disadvantaged businesses; 5 percent for women-owned small businesses (WOSBs); and 3 percent for Historically Underutilized Business Zone (HUBZone) businesses. These are participation goals, not automatic set-aside percentages or guarantees of award. Veteran-owned small businesses (VOSBs) do not have a separate government-wide statutory percentage, although they receive specific preference within Department of Veterans Affairs (VA) acquisitions.

Certification as an SDVOSB, VOSB, 8(a) participant, HUBZone business, or WOSB can affect who may compete and how an acquisition may be structured, including restricted competitions and sole-source authorities.

VA’s Veterans First framework gives priority to SDVOSBs and then VOSBs when the Rule of Two is satisfied. The Department of Defense (DoD) does not apply the same VA-specific priority. DoD contracting officers operate under Federal Acquisition Regulation (FAR) Part 19. There is no general order of precedence among the 8(a), HUBZone, SDVOSB, and WOSB programs; the selected pathway depends on the requirement, market research, program rules, agency goals, and capable sources.

Eligibility Does Not Replace Acceptability

Socioeconomic status changes the competitive pathway; it does not lower the requirement. An eligible company must still propose the product, services, delivery model, and evidence required by the solicitation. For a medical device, this may include technical specifications, intended clinical use, regulatory status, interoperability, cybersecurity, implementation, training, warranty, maintenance, and supply continuity. A designation cannot make a product technically acceptable or clinically suitable when it does not meet the agency’s stated needs.

Responsibility and Past Performance Remain Separate

Before award, the contracting officer must determine that the prospective contractor is responsible. Federal standards address financial resources, performance capacity and history, integrity, organization, experience, operational controls, equipment, and technical skills. A certified concern that fails to demonstrate these capabilities may be found non-responsible or fail another pre-award review.

Past performance may be evaluated separately. Agencies may consider the relevance, currency, context, and trends of prior work. An offeror without relevant history is not automatically rated negatively, but it must follow the solicitation’s evaluation method and identify permissible experience. Socioeconomic status does not convert unsupported experience into a favorable record.

Execution Risk Remains After Award

Product availability, importing, inventory, delivery, installation, training, service, complaint escalation, cybersecurity support, and recall readiness can determine whether an award results in clinical use. A credible strategy combines eligibility with a suitable product, a compliant proposal, performance evidence, and an operating model capable of delivering what was promised.

Align Eligibility With Federal Readiness

MDD Federal helps medical device companies align socioeconomic eligibility with technical, clinical, and operational readiness. Support can include opportunity qualification, acquisition-pathway analysis, teaming and channel structure, proposal positioning, responsibility and past-performance planning, and coordination of the import, inventory, fulfillment, and post-market infrastructure needed to execute.